Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Historical Holders from Q1 2023 to Q1 2025

Symbol
RNAC on Nasdaq
CUSIP
816212302
Type / Class
Equity / COMMON STOCK
Shares outstanding
25.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
6.67M
Holdings value
$119M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
37
Number of sells
-18
Average Value change %
-0.01%
Average buys %
+0%
Average sells %
-0.009%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRINGER TIMOTHY A 36.9% +0.27% $126M $280K 9.56M +0.22% Timothy A. Springer Jan 13, 2025
FMR LLC 9.4% $32M 2.42M FMR LLC Dec 31, 2024

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 13K $172K +$36.8K $13.22 3
2024 Q4 6.67M $119M -$2.7M $17.91 63
2024 Q3 6.87M $110M +$42.9M $16.12 61
2024 Q2 3.27M $88.3M +$88.1M $27.01 59
2024 Q1 1.86K $1.16K +$1.16K $0.64 4
2023 Q4 0 $0 -$1.27K 0
2023 Q3 1.2K $1.27K $0 $1.06 1
2023 Q2 1.2K $1.34K $0 $1.12 1
2023 Q1 1.2K $1.67K $0 $1.39 1